This is a 360 degree photo of a Siemens Somatom Force 64-slice, dual-source computed tomography (CT) system installed at ...
This is a dedicated cardiac Siemens 1.5T MRI system installed at the Baylor Scott White Heart Hospital in Dallas. The ...
Miami Cardiac & Vascular Institute announced the implementation of Philips’ Ingenia Ambition 1.5T MR, the world’s first magnetic resonance imaging (MRI) system to enable helium-free operations. The technology offers cutting-edge imaging techniques that deliver high-quality images faster while providing an improved, more comfortable experience for patients, according to Philips.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
With its increasing role in medical imaging, artificial intelligence (AI) gradually is becoming a go-to technology for ...
Biopharmaceutical company CellPoint plans to begin patient recruitment for its Phase 2b cardiovascular imaging study in patients suffering from coronary artery disease using the company's new one-vial Oncardia (ethylenedicysteine-glucosamine) kits. The 60-patient trial study is being conducted in the U.S.
According to the U.S. Department of Health and Human Services (HHS), about 70 percent of organizations are not compliant ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
May 17, 2019 — The U.S. Food and Drug Administration (FDA) this week approved Fragmin (dalteparin sodium) injection, for ...
Digital healthcare company Murj announced the availability of the Murj Analytics software-as-a-service (SaaS) platform for cardiac implantable electronic device (CIED) management. This new offering features powerful intelligence for cardiac device clinicians seeking to provide comprehensive population management through improved clinical, workforce and quality of care metrics.
At the 40th annual Heart Rhythm Scientific Sessions, May 8-11 in San Francisco, Acutus Medical announced the agreement to acquire Rhythm Xience Inc., and new strategic partnerships with Peerbridge Health, Cardiac Designs and MedFact. Acutus' expanded portfolio builds on the organization's mapping and visualization technology platform.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Preventice Solutions presented clinical data validating its BodyGuardian Remote Monitoring System with the BeatLogic deep learning platform at Heart Rhythm 2019, the Heart Rhythm Society’s 40th Annual Scientific Sessions, May 8-11 in San Francisco. This technology leverages machine learning and artificial intelligence (AI) for detection of atrial fibrillation (AF) and was validated using clinician adjudicated data.
Johnson & Johnson Medical Devices Companies announced the launch of Biosense Webster Inc.’s Cartonet to help electrophysiologists, hospitals, health systems, and researchers leverage and share data, with the goal of improving patient outcomes and operational efficiency in catheter ablation procedures. Announced at Heart Rhythm 2019, the Heart Rhythm Society's (HRS) 40th Annual Heart Rhythm Scientific Sessions, May 8-11 in San Francisco, Cartonet is the world’s first cloud-based networking and data analytics software solution for the field of electrophysiology, according to the company.
Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc.’s QDot Micro catheter demonstrated safety and efficacy in achieving pulmonary vein isolation in patients with symptomatic drug-refractory paroxysmal atrial fibrillation (AF).
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
The Heart Rhythm Society (HRS) 2019 Annual Scientific Sessions represent an important annual event for electrophysiology ...
CardioFocus Inc. announced the presentation of results from its pivotal confirmatory study evaluating the HeartLight X3 System for the treatment of atrial fibrillation (AFib). The results, which demonstrated superior procedural times and impressive procedural outcomes, according to the company, were presented during the Heart Rhythm Society's (HRS) 40th Annual Scientific Sessions, May 8-11, 2019 in San Francisco.
BioCardia Inc. announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Avance steerable introducer product family, designed for introducing various cardiovascular catheters into the heart, including via the left side of the heart through the interatrial septum.